CVS Health Corp vs Solaredge Technologies Inc — how do they compare? CVS Health Corp trades at $86.3 (market cap $112.49B), while Solaredge Technologies Inc trades at $32.72 (market cap $2.04B). The key difference: CVS Health Corp is far larger — about 55.1× Solaredge Technologies Inc's market cap, and CVS Health Corp pays a 3.02% dividend while Solaredge Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Solaredge Technologies Inc for 34 Days on average.
| CVS | SEDG | |
|---|---|---|
Market Cap | $112.49B | $2.04B |
Volume | 8,467,392 | 2,111,744 |
Sector | Health | Energy |
52-Week High | $110.60 | $78.51 |
52-Week Low | $70.08 | $28.47 |
Typical Hold Time | 83 Days | 34 Days |
Enterprise Value | $174.83B | $1.90B |
Dividend Yield | 3.02% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
SolarEdge Technologies (SEDG) trades at $32.47, down 4.61% on the day, amid a bearish technical outlook and mixed earnings performance. The company reported a net loss of $405.45M in 2025 with a negative net margin of -34.24%, though revenue grew to $1.18B. Analyst sentiment is cautious with a Hold consensus and a $37.75 price target, while recent news highlights legal investigations and volatility in the solar sector.
The outlook remains challenging due to persistent losses and competitive pressures, but long-term growth potential exists from AI data center initiatives targeting $2.4B revenue by 2029. Key risks include high debt, industry headwinds from borrowing costs, and ongoing legal probes. Investors should weigh the speculative growth narrative against fundamental weaknesses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →